General Information of Drug (ID: DMHGPZ8)

Drug Name
Hi8 melanoma vaccine
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Phase 2 [1]
Cross-matching ID
TTD ID
D04HMK

References

1 Phase I/II trial of Hi8 PrimeBoost therapeutic vaccine in stage III/IV metastatic melanoma. Melanoma Research. 09/2006; 16(Supplement 1).